Avoid risky UK pharma companies

Until recently, healthcare companies have been able to grow easily through a combination of new drug launches and higher prices. But this growth is not so easy to achieve now. Jeremy Lang, co-founder and partner of Ardevora Asset Management tells Investment Europe in the current environment, most companies are finding it harder to grow, making normal management behaviour risky.

Link

top